Search Results

There are 996 results for: content related to: Myasthenia gravis requiring pyridostigmine treatment in a national population cohort

  1. You have free access to this content
    Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

    The Journal of Physiology

    Volume 591, Issue 10, May 2013, Pages: 2747–2762, Marco Morsch, Stephen W. Reddel, Nazanin Ghazanfari, Klaus V. Toyka and William D. Phillips

    Version of Record online : 25 MAR 2013, DOI: 10.1113/jphysiol.2013.251827

  2. You have full text access to this OnlineOpen article
    Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling

    Journal of Cellular and Molecular Medicine

    Yi Lu, Ming Zhao, Jin-Jun Liu, Xi He, Xiao-Jiang Yu, Long-Zhu Liu, Lei Sun, Li-Na Chen and Wei-Jin Zang

    Version of Record online : 10 MAR 2017, DOI: 10.1111/jcmm.13133

  3. Cholinergic stimulation with pyridostigmine improves autonomic function in infarcted rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 9, September 2013, Pages: 610–616, Raquel N de La Fuente, Bruno Rodrigues, Ivana C Moraes-Silva, Leandro E Souza, Raquel Sirvente, Cristiano Mostarda, Kátia De Angelis, Pedro P Soares, Silvia Lacchini, Fernanda Consolim-Colombo and Maria-Cláudia Irigoyen

    Version of Record online : 23 AUG 2013, DOI: 10.1111/1440-1681.12121

  4. Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 9, September 2009, Pages: 1187–1196, Kok-Yong Seng, Weng-Keong Loke, Shabbir Moochhala, Bin Zhao and Jon-Deoon Edmund Lee

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.09.0008

  5. Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience

    Pacing and Clinical Electrophysiology


    Version of Record online : 16 MAR 2011, DOI: 10.1111/j.1540-8159.2011.03047.x

  6. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis

    Clinical Endocrinology

    Volume 53, Issue 5, November 2000, Pages: 587–593, Juan J. Díez, Pedro Iglesias, Rafael Selgas, María A. Bajo and Abelardo Aguilera

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2265.2000.01128.x

  7. Pyridostigmine enhances atrial tachyarrhythmias in aging spontaneously hypertensive rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 10, October 2015, Pages: 1084–1091, Halil Sayin, Alina Scridon, Valérie Oréa, Bruno Chapuis, Philippe Chevalier, Christian Barrès and Claude Julien

    Version of Record online : 15 SEP 2015, DOI: 10.1111/1440-1681.12458

  8. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis

    Muscle & Nerve

    Jorge Enrique Machado-Alba, Luis Felipe Calvo-Torres, Andrés Gaviria-Mendoza and César Augusto MejíA-Vélez

    Version of Record online : 23 MAR 2017, DOI: 10.1002/mus.25625

  9. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy

    Pediatric Anesthesia

    Volume 18, Issue 3, March 2008, Pages: 251–255, TINO MUENSTER, JUERGEN FORST, PETER GOERLITZ and HUBERT J. SCHMITT

    Version of Record online : 22 JAN 2008, DOI: 10.1111/j.1460-9592.2008.02417.x

  10. You have free access to this content
    Treatment for postpolio syndrome

    Intervention Review

    The Cochrane Library

    Fieke Sophia Koopman, Anita Beelen, Nils Erik Gilhus, Marianne de Visser and Frans Nollet

    Published Online : 18 MAY 2015, DOI: 10.1002/14651858.CD007818.pub3

  11. A national epidemiological study of Myasthenia Gravis in Australia

    European Journal of Neurology

    Volume 19, Issue 11, November 2012, Pages: 1413–1420, M. Gattellari, C. Goumas and J. M. Worthington

    Version of Record online : 2 APR 2012, DOI: 10.1111/j.1468-1331.2012.03698.x

  12. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion

    Environmental Toxicology and Chemistry

    Volume 20, Issue 9, September 2001, Pages: 2008–2013, Sebastián Sánchez-Fortún and Victoria Barahona

    Version of Record online : 3 NOV 2009, DOI: 10.1002/etc.5620200920

  13. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine

    Colorectal Disease

    Volume 12, Issue 6, June 2010, Pages: 540–548, C. J. O’Dea, S. J. H. Brookes and D. A. Wattchow

    Version of Record online : 27 MAR 2009, DOI: 10.1111/j.1463-1318.2009.01838.x

  14. Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert–Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 1, July 2009, Pages: 44–48, PW Wirtz, JJ Verschuuren, JG van Dijk, ML de Kam, RC Schoemaker, JGC van Hasselt, MJ Titulaer, UR Tjaden, J den Hartigh and JMA van Gerven

    Version of Record online : 8 APR 2009, DOI: 10.1038/clpt.2009.35

  15. You have free access to this content
    Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin tone

    Arthritis & Rheumatism

    Volume 46, Issue 5, May 2002, Pages: 1344–1350, Eduardo S. Paiva, Atul Deodhar, Kim D. Jones and Robert Bennett

    Version of Record online : 8 MAY 2002, DOI: 10.1002/art.10209

  16. Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl

    Journal of Applied Toxicology

    Volume 35, Issue 5, May 2015, Pages: 493–499, Georg A. Petroianu, Syed M. Nurulain, Mohamed Y. Hasan, Kamil Kuča and Dietrich E. Lorke

    Version of Record online : 3 SEP 2014, DOI: 10.1002/jat.3052

  17. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors

    Journal of Applied Toxicology

    Volume 31, Issue 6, August 2011, Pages: 515–523, Dietrich E. Lorke, Mohamed Y. Hasan, Syed M. Nurulain, Mohamed Shafiullah, Kamil Kuča and Georg A. Petroianu

    Version of Record online : 27 OCT 2010, DOI: 10.1002/jat.1589

  18. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases

    Muscle & Nerve

    Volume 54, Issue 3, September 2016, Pages: 413–421, Ernestina Santos, Ester Coutinho, Isabel Moreira, Ana Martins Silva, Dina Lopes, Henrique Costa, Fernando Silveira, Goreti Nadais, Hugo Morais, João Martins, Maria Ceu Branco, Andreia Veiga, Rosa Santos Silva, Augusto Ferreira, Filipa Sousa, Marta Freijo, Ilda Matos, Rui André, Luís Negrão, Carla Fraga, Manuela Santos, Mafalda Sampaio, Carlos Lopes, Maria Isabel Leite and Guilherme Gonçalves

    Version of Record online : 4 JUL 2016, DOI: 10.1002/mus.25068

  19. Effect of atropine and pyridostigmine on growth hormone response to GH-releasing peptide-2 and GH-releasing hormone in swine

    Animal Science Journal

    Volume 74, Issue 2, April 2003, Pages: 129–136, Vonika NOU, Kyouko TOMOSHI, Hiroaki INOUE, Hideto KUWAYAMA and Hisashi HIDARI

    Version of Record online : 1 APR 2003, DOI: 10.1046/j.1344-3941.2003.00097.x

  20. Improving cardiac autonomic function following myocardial infarction: The case for anticholinesterase drugs

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 9, September 2013, Pages: 597–599, Colleen J Thomas

    Version of Record online : 23 AUG 2013, DOI: 10.1111/1440-1681.12146